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Summary
Objective: This study addresses the effects of tumor necrosis factor-a (TNF-a) and interleukin-1b (IL-1b) on cell death in human chondrocytes.
Methods: Osteoarthritis (OA) human chondrocytes stimulated with Actinomycin-D (ActD) were used as a cellular apoptotic model. Caspase
family mRNA expression and protein synthesis were analyzed by the ribonuclease protection assay and Western-blot, respectively. Cell vi-
ability and apoptosis were evaluated using the 3-[4,5-dimethylthiazol-2yl] 2,5-diphenyl tetrazolium bromide (MTT) assay and ﬂow cytometry,
respectively. Prostaglandin E2 (PGE2) and nitric oxide (NO) were evaluated by enzyme-linked immunosorbent assay (ELISA) and the Griess
method, respectively.
Results: TNF-a and IL-1b differentially affected the pattern of caspase mRNA expression by human chondrocytes. TNF-a induced a gradual
increase in caspase-1 and -8 mRNA levels that was not seen with IL-1b. The time sequence of caspase-3 and -7 inductions by TNF-a differs
from that induced by IL-1b. Cell viability was not modiﬁed by TNF-a or IL-1b in cultured chondrocytes. Then, we employed ActD as a model to
facilitate cell death. Treatment with TNF-a and ActD (TNF-a/ActD) increased cell death induced by ActD (23%). Treatment with IL-1b and ActD
(IL-1b/ActD) did not modulate ActD-induced cell death. Similarly, IL-1b/ActD did not induce an increase in the activation of caspase-3 and -7
and poly (ADP-ribose) polymerase (PARP) cleavage observed by the incubation with TNF-a/ActD. These different effects were not due to bcl-
2 or mcl-1 levels. Inhibition of PGE2 synthesis by indomethacin increased the cell death induced by IL-1b/Act-D (59%). An inhibitor of caspase-
8 signiﬁcantly reduced only the TNF-a/ActD-induced cell death (58%).
Conclusion: TNF-a and IL-1b differentially regulate the apoptotic pathway in human chondrocytes. This difference is dependent on PGE2 and
caspase-8 levels.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The cytokines, tumor necrosis factor-a (TNF-a) and interleu-
kin-1b (IL-1b), are particularly important in the pathophysiol-
ogy of cartilage disease1. They are indirectly responsible
for cartilage degradation and chondrocyte death and can
stimulate inﬂammatory mediators, such as IL-8, IL-6 and
leukocyte inhibitory factor (LIF), proteases, prostaglandin
E2 (PGE2) and nitric oxide (NO) production
2. Some studies
have suggested that TNF-a may inhibit the differentiation
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expression of the p55 TNF-a receptor has been localized
in cells at sites of focal loss of cartilage proteoglycans in
human osteoarthritis (OA) cartilage4. The number of type I
IL-1 receptor (IL-1R) has been shown to be signiﬁcantly
increased in OA chondrocytes and synovial cells, giving
these cells a higher sensitivity to stimulation by IL-1b5.
Studies in OA animal models have also demonstrated the
chondroprotective effects of anti-cytokine therapy6,7. Both
in vitro and in vivo studies showed that the effects of TNF-
a were similar to or synergistic with IL-1b8. However, the
effect of these cytokines on chondrocyte cell death is
controversial.
Chondrocytes are normally resistant to the induction of
apoptosis by IL-1b stimulation9. It has also been reported
that IL-1b protects chondrocytes from CD-95-induced apo-
ptosis by a mechanism that was independent of IL-1b-
induced NO9. However, conﬂicting results have been
reported showing that IL-1b induced apoptosis in human
articular chondrocytes10. The induction of chondrocyte apo-
ptosis by TNF-a is also arguable because different reports
yielded different results. The resistance to cell death of nor-
mal chondrocytes exposed to TNF-a or IL-1b is thought to
rely on the ability of TNF-a and IL-1b signaling to upregulate
protective cellular genes. Recently, our group and others
described that TNF-a and IL-1b induced bcl-2 and mcl-160
661Osteoarthritis and Cartilage Vol. 14, No. 7expression, two anti-apoptotic proteins9,11. Furthermore,
TNF-a protects human primary articular chondrocytes
from NO-induced apoptosis via nuclear factor-kB12. The
opposite results were obtained in chicken chondrocytes,
where TNF-a induced apoptosis. Moreover, it has been
described that proteosome inhibition and RNA synthesis
inhibition sensitize chondrocytes to TNF-a-mediated apo-
ptosis through distinct cell death pathways13. These differ-
ing results suggest that the pro-apoptotic or anti-apoptotic
effects of IL-1b or TNF-a may depend upon the experimen-
tal model. Differences in culture conditions (cell density, cell
lines, monolayer or alginate beads) and/or cartilage sam-
ples (young, mature or aged) used for cell culture may
also play a part in this controversy. For all these reasons,
a signiﬁcant aspect of this work is that the relationships
between two key cytokines in the pathophysiology of articular
disease and chondrocyte death were tested in the same
experimental model and with the same culture conditions.
Several previous papers have routinely employed the
addition of Actinomycin-D (ActD) to facilitate cell death in
different cell types13e17. ActD, a DNA-dependent RNA
polymerase inhibitor, may sensitize much kind of cells to
facilitate apoptosis by blocking upregulation of an NF-kB
dependent protective gene15. Some genes induced by
NF-kB act to suppress cytokine induced apoptosis, thereby
explaining why the apoptotic response to cytokines is usu-
ally dependent on inhibition of RNA or protein synthesis18.
ActD increases the expression of Fas-associated death
domain (FADD)19, and down-regulates FADD-like interleukin-
1 converting enzyme (ICE) (FLICE)-inhibitory protein
(FLIP)16 and activates caspases. Finally, at short times
ActD alone does not affect the expression of apoptosis-re-
lated proteins (bcl-2, Bax, and FLIP) in chondrocytes13.
The present study demonstrates that both TNF-a and
IL-1b differentially regulate the activation of the apoptotic
pathway in human chondrocyte cells. We demonstrate that
this difference could be largely dependent on PGE2 and
caspase-8 levels. These ﬁndings may provide new clues
for the understanding of the cartilage degradation process
in articular disease.
Materials and methods
CULTURE OF CHONDROCYTES
Human OA chondrocytes were obtained, as previously
described, from cartilages of patients who were undergoing
hip joint replacement surgery at the Orthopaedic Depart-
ment of the Complexo Hospitalario Universitario Juan
Canalejo20. Brieﬂy, cartilage slices were minced and incu-
bated with trypsin (0.5 mg/ml) (Sigma Chemical Co., St.
Louis, MO, USA) for 15 min at 37(C, after which the carti-
lage was treated with 2 mg/ml clostridial collagenase
(Sigma) in Dulbecco’s modiﬁed Eagle’s medium (DMEM,
Gibco, UK) with 5% fetal calf serum (FCS, Gibco) overnight
at 37(C with shaking. The digest was centrifuged and the
cells were resuspended in FCS-enriched DMEM and cul-
tured in ﬂasks. Subcultures were performed with trypsine
ethylenediaminetetraacetic acid (EDTA) (Gibco) and ﬁrst
passage cells were used. This study was approved by the
Ethics Committee of Galicia, Spain.
CELL STIMULATION OF CHONDROCYTES
Chondrocytes were seeded either into tissue culture
100 mm-plate (Costar, Corning, NY, USA) for RNA or total
protein extraction, 12-well plates (Costar) for ﬂow cytometricanalysis, or 96-well plates (Costar) for viability, NO or PGE2
detection. When cells reached conﬂuency, they were made
quiescent by incubating for 48 h in medium containing 0.5%
FCS and then stimulated with the usual dosage of cyto-
kines9, TNF-a (1, 10 and 100 ng/ml) (R&D Systems,
Europe) or IL-1b (0.5, 5 and 50 ng/ml) (R&D), in the pres-
ence or absence of ActD (1 mg/ml) (Sigma). In the case of
loss of cell viability and detachment, all cells (ﬂoating and
attached) were combined in the same assay. In some
cases, cells were preincubated for 2 h with inhibitors of
the caspases: caspase-8 inhibitor (Z-IETD-FMK, 100 mM)
(BD Pharmingen, Heidelberg, Germany); caspase 3/7 inhib-
itor (5-[(S )-()-2-(methoxymethyl)pyrrolidino]sulfonylisatin,
100 mM) (Calbiochem, VWR International, Spain) or a gen-
eral caspase inhibitor (Z-VAD-FMK, 100 mM) (BD)13; or an
inhibitor of cyclooxygenase (COX) (indomethacin, 140 mM)
(Sigma)21, and then cells were stimulated with cytokines.
CELL VIABILITY
Cell viability was evaluated using the 3-[4,5-dimethylthia-
zol-2yl] 2,5-diphenyl tetrazolium bromide (MTT) assay
(Roche Diagnostics, Mannheim, Germany). For this assay,
10 ml of MTT (5 mg/ml in phosphate buffered saline (PBS))
was added to the wells and the plate was incubated for four
additional hours. Thereafter, 100 ml of a solubilization solu-
tion (10% sodium dodecyl sulphate (SDS) in 0.01 M HCl)
was added to dissolve the water-insoluble formazan salt.
Quantiﬁcation was then carried out with an enzyme-linked
immunosorbent assay (ELISA) reader at 570 nm (Amer-
sham, Buckinghamshire, UK). The results are expressed
as the percentage of MTT cleaved to form a formazan
dye per 104 cells.
FLOW CYTOMETRIC ASSESSMENT OF CELL DEATH
Cellular DNA content was assessed as described previ-
ously by ﬂow cytometry20. For this purpose, cells were cul-
tured in 12-well plates and treated as appropriate. Cells
attached to the plate were collected with trypsin and mixed
with detached cells present in the supernatant. Cells were
spun and resuspended in a solution containing 50 mg/ml
propidium iodide (PI) (Sigma), 1 mg/ml RNAse A (Sigma),
and 0.01% NP-40 (Sigma) in PBS; then they were incu-
bated at 4(C for 30 min in the dark and analyzed by ﬂow
cytometry on a FACScan (BD) using a 560 nm dichromatic
mirror and a 600 nm band pass ﬁlter. The percentage of
cells with decreased DNA staining composed of apoptotic
cells resulting from either fragmentation or decreased chro-
matin, of a minimum of 10,000 cells per experimental condi-
tion was counted. The data are expressed as the
percentage of apoptotic (hypodiploid) nuclei. Cells with
a very low DNA content, in which the type of cell death
could not be ascertained, were excluded from the analysis.
As assayed by ﬂow cytometry, none of the solvents of differ-
ent compounds, up to the highest dose used in our experi-
mental conditions induced any signiﬁcant degree of
apoptosis.
RNA ISOLATION AND RIBONUCLEASE PROTECTION ANALYSIS
Total RNA was extracted from chondrocytes by the
guanidine isothiocyanateephenolechloroform method22.
The probe, obtained from BD Pharmingen, and the ribonu-
clease protection assay were carried out according to the
instructions of the manufacturer (BD Pharmingen). Brieﬂy,
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CTP (Amersham) were synthesized from linearized plasmids
using T7 RNA polymerase (BD Pharmingen). Approxi-
mately 106 cpm of probe was hybridized overnight at
56(C with 10e12 mg of total RNA in 10 ml of hybridization
buffer. Unhybridized RNA was digested for 45 min at 30(C
in 100 ml RNAse solution. Then, 18 ml of proteinase K cock-
tail was added to each sample and incubated for 15 min at
37(C to remove the nucleases. The mixture was extracted
with phenol/chloroform/isoamyl alcohol and precipitated
with ethanol. The protected fragments were analyzed on
6% TBEeUrea gel (Invitrogen, Paisley, Scotland, UK) and
by subsequent autoradiography with X-OMAT AR ﬁlm
(Eastman Kodak, Rochester, NY, USA) with different expo-
sition times for caspase mRNA and L-32. In order to quantify
the relative amounts of mRNA of the caspases, the pro-
tected RNA fragments were scanned by bidimensional laser
densitometry (Image Quant, Amersham). Data were stan-
dardized to the housekeeping gene L-32 (ribosomal protein
p32), and results were expressed as the percentage of basal
gene expression as arbitrary densitometric units.
WESTERN-BLOT
After appropriate stimulation, cells were washed in ice-
cold PBS, pH 7.5, and lysed in 0.2 M TriseHCl, pH 6.8, con-
taining 2% SDS, 20% glycerol, 1 mg/ml cocktail inhibitor
(Sigma) and 1 mM phenyl methyl sulfonyl ﬂuoride (PMSF)
(Sigma). Whole cell lysates were boiled for 5 min and pro-
tein concentrations were determined using a Bicinchoninic
acid (BCA) reagent assay (Pierce Chemical Co., Rockford,
IL, USA). The protein extracts (30 mg) were resolved on
12.5% SDS-polyacrylamide gels (SDS-PAGEs) and trans-
ferred to polyvinylidene diﬂuoride membranes (Immobilon
P, Millipore Co., Bedford, MA, USA). Membranes were ﬁrst
blocked in Tris buffered saline, pH 7.4 containing 0.1%
Tween-20, and 5% nonfat dried milk for 60 min at room tem-
perature and then incubated overnight with anti-caspase-3
(rabbit anti-human caspase-3, 1:1000, BD) or anti-cas-
pase-7 (mouse anti-human caspase-7, 1:1000, BD) or
anti-poly (ADP-ribose) polymerase (anti-PARP) (mouse
anti-human PARP, 1:500, BD) or anti-bcl-2 (mouse anti-hu-
man bcl-2, R&D, Abingdon, UK) or anti-mcl-1 (mouse anti-
human mcl-1, 1:500, Oncogene, Boston, MA, USA) at
4(C. After washing, the membranes were incubated with
peroxidase conjugated secondary antibodies and devel-
oped using an ECL chemiluminescence kit (Amersham).
In order to assure that equal amounts of total proteins
were charged, we also hybridized each membrane with
anti-tubulin (Sigma).
QUANTIFICATION OF NITRITES
The NO production was measured by the Griess reagent
as previously described20. Brieﬂy, the culture supernatant
(50 ml) was incubated with 50 ml 1% sulfanilamide, 0.1%
N-1 naphthylethylenediamidedihydrochloride in 2.5% H3PO4
at room temperature for 5 min. The absorbance at 570 nm
was measured and compared with a standard of NaNO2.
The production of NO was expressed as mM of NO2
 per
5 104 cells.
QUANTIFICATION OF PGE2
The amounts of PGE2 in the conditioned media were de-
termined by a commercially available ELISA kit (Amersham)
according to the manufacturer’s instructions. The sensitivityof the assay was 40 pg/ml, and the working range was be-
tween 50 and 6400 pg/ml.
STATISTICAL ANALYSES
The data are expressed as the mean standard error of
the mean (S.E.M.) from determinations (n) or as representa-
tive results, as indicated. The statistical software program,
SPSS (version 10.0, SPSS, Chicago, IL, USA) was used
to perform analysis of variance (ANOVA) or Tukey tests.
Differences were considered to be statistically signiﬁcant
at P< 0.05.
Results
IL-1b AND TNF-a DIFFERENTIALLY STIMULATE THE GENE
EXPRESSION OF CASPASE FAMILY PROTEINS IN HUMAN
CHONDROCYTES
Because opinions are divided about the susceptibility of
chondrocytes to cell death caused by both TNF-a and IL-
1b and because the caspase family appears to be the
most responsible for the execution of apoptosis, we studied
the modulation of caspases by these cytokines. Each cyto-
kine produces a unique pattern of caspase family mRNA
expression in human chondrocytes [Fig. 1(A)]. IL-1b treated
chondrocytes showed a rapid rise of caspase-3 and -7
mRNA expressions by 6 h after stimulation, but this began
to diminish at 24e72 h. TNF-a treated chondrocytes also
showed a rapid rise of caspase-3 and -7 by 6 h after stimu-
lation, reaching a maximum at 24 h; its production was
maintained even at 72 h [Fig. 1(A)]. Stimulation of cells
with TNF-a showed a gradual increase in caspase-8
mRNA levels [Fig. 1(A)]. Interestingly, IL-1b treatment did
not appreciably modify caspase-8 mRNA expression
[Fig. 1(A)]. The mRNA expression of caspase-1 and -5
was only elicited by TNF-a, not by IL-1b [Fig. 1(A)].
The doseeresponse of caspase family mRNA expression
by chondrocytes treated with TNF-a or IL-1b was studied,
and a dose-dependent curve was observed for caspase-3,
-7, -8, and -1 when chondrocytes were stimulated with
TNF-a and for caspase-3 and -7 when chondrocytes were
incubated with IL-1b, reaching a plateau between 1 and
10 ng/ml for TNF-a and between 0.5 and 5 ng/ml for IL-1b
(data not shown). Finally, the levels of caspase-2 and cas-
pase-6 were not noticeably modiﬁed at any time or dosage
employed. No mRNA for granzyme B, an activator of both
effector caspases and initiator caspases, was detected in
chondrocyte cells [Fig. 1(A)].
The increase in the expression of caspase family mRNA
from cultured chondrocytes was accompanied by the syn-
thesis of protein intermediates and/or active forms of the
caspases. The expression of the 35-kDa unprocessed
pro-caspase-7 and 32-kDa unprocessed pro-caspase-3
was upregulated in cultured chondrocyte cells after treat-
ment with either TNF-a or IL-1b [Fig. 1(B)]. However, their
active fragments (17 kDa forms both caspases) were not
detected. In consequence, PARP, a substrate of activated
caspase-3, was not cleaved [Fig. 1(B)].
IL-1b AND TNF-a DIFFERENTIALLY REGULATE CELL DEATH
IN CHONDROCYTES SENSITIZED BY ActD
Because neither cytokine, TNF-a or IL-1b, is capable of
inducing cell death [Fig. 2(A)] and each cytokine differentially
regulates caspases, which drive the apoptotic pathway,
both cytokines could drive different outcome in human
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Fig. 1. IL-1b and TNF-a differentially stimulate the gene expression of caspase family proteins in human chondrocytes. Conﬂuent chondro-
cytes were incubated for the indicated time intervals (6, 12, 24 and 72 h) (A), both in basal conditions or in the presence of IL-1b (5 ng/ml)
or TNF-a (10 ng/ml). At the indicated time intervals, total RNA was isolated and caspase family mRNA expression was analyzed by the ribo-
nuclease protection assay as described in Materials and methods. This blot is representative of a total of three experiments. L-32¼ ribosomal
protein p32. In (B), conﬂuent chondrocytes were incubated for 36 h, both in basal conditions or in the presence of IL-1b (5 ng/ml) or TNF-
a (10 ng/ml) and total cell lysate from cells was analyzed by Western-blot with antibody against the 35 kDa unprocessed pro-caspase-7,
32-kDa unprocessed pro-caspase-3, poly(ADP-ribose) polymerase (PARP) and tubulin protein. Molecular size markers are shown on the
left. One representative of four experiments is shown.chondrocytic cell death. For this reason, several biochemi-
cal and morphological tests were performed in a model of
cell death induced by the inhibitor of transcription, ActD.
As shown in Fig. 2(B), TNF-a, in combination with ActD
(TNF-a/ActD), increased the loss of cell viability induced
by ActD alone in a dose-dependent manner. Interestingly,
IL-1b did not show this synergistic effect with ActD
[Fig. 2(AeC)]. Thus, there is a signiﬁcant difference between
the loss of viability induced by TNF-a/ActD and by IL-1b and
ActD (IL-1b/ActD). These results are in agreement with the
time-course ﬂow cytometric analysis, which showed that
the increased hypodiploid DNA peak induced by ActD was
ampliﬁed by TNF-a, but not by IL-1b [Fig. 2(D)]. Nuclearmorphology studies by DAPI showed that treatment with
TNF-a/ActD resulted in a high number of cells with con-
densed nuclei. However, IL-1b/ActD treatment of chondro-
cytes did not elicit this effect (data not shown).
Finally, inactive caspase-7 (35 kDa) was clearly reduced
in TNF-a/ActD treated chondrocytes, indicating the activa-
tion of caspase-7 (Fig. 3). Following the activation of cas-
pase-7, the level of 32 kDa inactive caspase-3 also
declined in TNF-a/ActD treated cultured chondrocytes. In
addition, PARP cleavage occurred within 36 h after TNF-
a/ActD treatment (Fig. 3). However, IL-1b/ActD did not
induce an increase in the activation of caspase-3 and
-7 nor PARP cleavage.
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Fig. 2. Differential interaction of IL-1b and TNF-a with the cell death stimulator, ActD. (A) Cell viability studies were made on human chondro-
cytes that were incubated in 96-well plates in basal conditions or with IL-1b (5 ng/ml), TNF-a (10 ng/ml), ActD (1 mg/ml), or treated with IL-1b
and ActD (5 ng/ml and 1 mg/ml, respectively) or TNF-a and ActD (10 ng/ml and 1 mg/ml, respectively). At the indicated times (24, 48, 72 and
168 h), cell viability was evaluated in both ﬂoating and attached cells using a colorimetric assay based on the MTT assay. Data are expressed
as percentages with respect to basal conditions and represent mean S.E.M. of six independent experiments in triplicate. (*P< 0.01 vs TNF-a/
ActD). In (B), chondrocytes were incubated for 24 h with ActD (1 mg/ml) and increasing concentrations of TNF-a (1, 10 and 100 ng/ml). In (C),
chondrocytes were incubated for 72 h with ActD (1 mg/ml) and increasing concentrations of IL-1b (0.5, 5 and 50 ng/ml). In B and C, data are
expressed as percentages with respect to ActD conditions, and represent the mean S.E.M. of six independent experiments in triplicate. (D)
Flow cytometry analyses of the DNA content in PI stained cells were made in human chondrocytes that were incubated in 12-well plates for 12,
24 and 48 h with IL-1b (5 ng/ml), TNF-a (10 ng/ml), ActD (1 mg/ml), or treated with IL-1b and ActD (5 ng/ml and 1 mg/ml, respectively) or TNF-a
and ActD (10 ng/ml and 1 mg/ml, respectively). Data representating the mean  S.E.M. of the percentage of cells with hypodiploid DNA
content of four independent experiments in triplicate (*P< 0.01 and $P< 0.001 vs basal; **P< 0.001 vs ActD; ***P< 0.001 vs IL-1þ ActD).
S.E.M.¼ standard error of the mean.
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INTERACTION OF IL-1b AND TNF-a WITH ActD
To investigate the explanation of the different effects of
TNF-a and IL-1b on the apoptosis induced by ActD, we ﬁrst
analyzed the role of some anti-apoptotic proteins. As indi-
cated in Fig. 4, both TNF-a and IL-1 b induced bcl-2 and
mcl-1 protein expression in human chondrocytes. However,
in the presence of ActD, bcl-2 and mcl-1 protein expression
was not induced by treatments with either TNF-a or IL-
b (Fig. 4). This suggests that transcription of RNA, presum-
ably bcl-2 and mcl-1 mRNA, is required for the increased
bcl-2 and mcl-1 protein production in the same manner by
TNF-a and IL-1b. These results suggest that bcl-2 and
mcl-1 are not responsible for the differential response of
IL-1b and TNF-a in this in vitro model of cell death.
IMPLICATION OF NO AND PGE2 IN THE DIFFERENTIAL
INTERACTION OF IL-1b AND TNF-a WITH ActD
Different reports have implicated NO in cell death23,24. To
assess the possible implication of NO in the differential in-
teraction of IL-1b and TNF-a in metabolically inhibited cells,
we ﬁrst evaluated the ability of these cytokines to induce
NO in chondrocytes. Our results showed that stimulation
of human chondrocytes with either IL-1b or TNF-a signiﬁ-
cantly increased NO production [Fig. 5(A)]. The presence
of ActD in the culture medium signiﬁcantly reduced to basal
levels the NO induced by both IL-1b and TNF-a [Fig. 5(A)].
These data indicate that the different responses of these
cytokines on cellular survival, are not inﬂuenced by the
production of endogenous NO.
Because PGE2 also modulates cell death in human OA
chondrocytes25, we also evaluated the relationship between
PGE2 and the differential response of IL-1b and TNF-a in
metabolically inhibited cells. We measured PGE2 release
after treatment of chondrocytes with IL-1b or TNF-a and
found that both increased PGE2 synthesis [Fig. 5(B)];
however, the effect of IL-1b on PGE2 synthesis was much
stronger than that of TNF-a. When ActD was present
in the culture medium, the PGE2-induction by IL-1b was
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Fig. 3. Differential caspase activation and subsequent cleavage of
PARP by treatments with IL-1b and TNF-a in human chondrocytes.
Aliquots of total cell lysates were ﬁrst subjected to SDS-PAGE; im-
munoblotting was performed using anti-caspase-3, -7, and anti-
PARP antibodies as described in Materials and methods. Proteins
were isolated from untreated cells, cells treated with IL-1b (5 ng/ml)
or TNF-a (10 ng/ml), with or without ActD (1 mg/ml) for the indicated
time (36 h). Molecular size markers are shown on the left. Data are
representative of four separate experiments.signiﬁcantly reduced to near-basal levels; however, PGE2-
induction by TNF-a was not modiﬁed [Fig. 5(B)].
In order to determine whether PGE2 production contrib-
utes to the differing responses of IL-1b and TNF-a to
the apoptosis induced by ActD, we used a COX inhibitor,
indomethacin. Incubation of chondrocytes for 2 h with
indomethacin (140 mM), followed by the co-incubation of
TNF-a/ActD or IL-1b/ActD for 24 h, increased the hypodip-
loid peak induced by TNF-a/ActD or IL-1b/ActD alone
[Fig. 5(C)]. This increase was signiﬁcantly (P< 0.001)
higher with IL-1b/ActD (59%) than with TNF-a/ActD
(27%). The hypodiploid peak was not signiﬁcantly modiﬁed
in unstimulated controls by indomethacin used at the indi-
cated concentration (data not shown). These data revealed
that PGE2 appears to have a protective function in this
model of cell death and that the high levels of PGE2 in-
duced by IL-1b may protect chondrocytes from cell death
induced by ActD.
ROLE OF CASPASES IN THE DIFFERENTIAL
INTERACTION OF IL-1b AND TNF-a WITH ActD
To elucidate the role of the caspases on the effect of
TNF-a/ActD or IL-1b/ActD on chondrocyte cell death in-
duced by ActD, we employed a caspase-8, caspase 3/7
and a general caspase inhibitor. Both the general caspase
and caspase-8 inhibitor signiﬁcantly decreased the hypo-
diploid DNA peak in response to treatment with TNF-a/
ActD (Fig. 6). In addition, the caspase 3/7 inhibitor de-
creased, but not signiﬁcantly, the hypodiploid peak in re-
sponse to treatment with TNF-a/ActD (Fig. 6). However,
the cell death induced by IL-1b/ActD was signiﬁcantly pre-
vented only by the caspase general inhibitor (Fig. 6). The
hypodiploid DNA peak was not affected in unstimulated
controls by either inhibitor used at the indicated concentra-
tions (data not shown). These results point to possible
different requirements for caspases during TNF-a/ActD or
IL-1b/Act interactions.
Discussion
In most human articular diseases, chondrocyte death
and the reduction of tissue cellularity may represent an
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Fig. 5. Implication of NO and PGE2 in the differential interaction of
IL-1b and TNF-a with the cell death stimulator, ActD. (A) Production
of NO by human chondrocytes incubated in medium alone or
treated with IL-1b (5 ng/ml) or TNF-a (10 ng/ml), with or without
ActD (1 mg/ml), was measured at 48 h by the Griess reaction. Nitrite
production is expressed as the mean S.E.M. of four experiments
performed in triplicate (*P < 0.001 and **P < 0.05 vs basal;
&P< 0.001 vs IL-1 and &&P< 0.05 vs TNF-a). (B) Chondrocytes
were stimulated as described above for 48 h and PGE2 released
into culture medium was measured by enzyme immunoassay.
PGE2 levels are expressed as the mean S.E.M. of six experiments
performed in triplicate) (*P< 0.001 vs basal and &P< 0.001 vs
IL-1). (C) Flow cytometry analysis of the DNA content of PI stained
in cells pretreated with the COX inhibitor, indomethacin (140 mM),
for 2 h, followed by co-incubation with IL-1b/ActD or TNF-a/ActD
for an additional 24 h. Percentage of cells with hypodiploid DNA
content induced by IL-1b/ActD or TNF-a/ActD was taken as
100% for respective comparisons vs indomethacin. Values are
means  S.E.M. of six experiments performed in tripl icate
(*P< 0.001 vs no COX inhibitor and &P< 0.001 vs IL-1/ActD).
S.E.M.¼ standard error of the mean.important step in the pathogenesis of cartilage destruc-
tion26,27. The cytokines, IL-1b and TNF-a, are particularly
important in the pathophysiology of cartilage disease, how-
ever, the precise roles they play in chondrocyte survival
remain unknown. In this report, we have demonstrated that
IL-1b and TNF-a differentially regulate the activation of the
apoptotic pathway in human chondrocytes and that this dif-
ference is dependent on levels of PGE2 and caspase-8.
There is an increase in mRNA levels of the executioner cas-
pase-3 and -7, showed by the increase in the expression of
32 kDa inactive caspase-3 and -7 in cultured OA chondro-
cytes after treatment with the cytokines TNF-a and IL-1b.
Thus, susceptibility to ActD-mediated apoptosis is concor-
dant with the expression of mRNA and inactive caspase-3
and -7 in cultured OA chondrocytes. The mRNA expression
of caspase-8, the most apical caspase in the signal trans-
duction cascade, was gradually increased by TNF-a treat-
ment. However, IL-1b did not modify it signiﬁcantly. Each
cytokine had a different time-dependent upregulation of
the mRNA expression of executioner caspase-3 and -7.
The caspase-3 and -8 mRNA levels in unstimulated cells
are comparable between them, similar to those observed
by Lotz and collaborators28 which conﬁrmed by reverse tran-
scriptase polymerase chain reaction (RT-PCR) analysis the
presence of equivalent amounts of caspase-3 and caspase-
8 mRNA in human chondrocytes. As it was commented, the
induction of the mRNA expression of executioner caspase-3
and -7 by both cytokines was accompanied by the protein
synthesis of their intermediate forms, but not their active
forms. In consequence, PARP, a substrate of activated cas-
pase-3, was not cleaved. This is in agreement with other
reported observations showing that OA synoviocytes, which
are insensitive to Fas-mediated apoptosis, acquire suscep-
tibility to Fas-mediated apoptosis after priming with TNF-a
through upregulation of the intermediate forms of caspase-3
and -829. Relative to IL-1b, no changes in inactive caspase-3
protein expression as a result of IL-1b stimulation were ob-
served at short times by Lotz and collaborators9. In relation
to the levels of caspases that have a specialized role in
inﬂammation and their activation leads to the processing of
pro-inﬂammatory cytokines, as caspase-1 and -5, in this
study we found that interestingly caspase-1 and -5 mRNA
expression was only elicited by TNF-a. Caspase-1, also
called ICE, is an enzyme which changes the inactive precur-
sor pro-IL-1b to its active form, IL-1b, and has recently been
identiﬁed as a key enzyme in apoptotic cell death. ICE is
related to the ﬁnal stages of apoptosis in a protease cas-
cade. Besides, granzyme B mRNA, an activator of effector
caspases as well as of initiator caspases, was not detected
in chondrocytes indicating that these enzymes could not be
implicated in this model of chondrocyte cell death.
It has been previously demonstrated that both TNF-a and
IL-1b induce the anti-apoptotic family, bcl-29e11. We show
here that (1) neither cytokine is capable of inducing cell
death and that (2) each cytokine differentially regulates the
activation of the caspases, which drive the apoptotic path-
way in human chondrocytes. Therefore, TNF-a and IL-1b
could each drive a different outcome in human chondrocytic
cell death. In this sense, we proved that IL-1b and TNF-a
differentially regulate ActD-induced apoptosis in cultured
human chondrocytes. The combined treatment of TNF-a
with ActD caused an increase of cell death in a dose- and
time-dependent manner, that, interestingly, was not found
using IL-1b with ActD. When levels of pro-caspase-3 and
-7 were evaluated, it was found that the IL-1b/ActD combina-
tion did not induce an increase in the activation of caspase-3
and -7 observed by incubation with TNF-a/ActD. Related to
667Osteoarthritis and Cartilage Vol. 14, No. 7this, no PARP cleavage could be detected by incubation
with IL-1b/ActD, but it did occur after treatment with TNF-
a/ActD. Similar results have been reported showing that, in
the apoptosis induced by TNF-a/ActD, caspase-3 plays an
important role, since caspase-3 processing was observed
as early as 6 h after ActD/TNF-a treatment which occurred
before apoptotic cell death was discernible9.
Next, we tried to deﬁne the different molecular mecha-
nisms of sensitization to IL-1b and TNF-a-induced apoptosis
by ActD in chondrocytes. In this work we demonstrated that
bcl-2 and mcl-1 decreased in the same manner in the pres-
ence of ActD. This would seem to indicate that bcl-2 and
mcl-1 arenot responsible for thedifferencesbetween theabil-
ities of IL-1bandTNF-a to initiate pro-apoptotic signaling cas-
cades. However, a previous study reported that bcl-2 protein
did not change after the combined treatment of ActD andTNF
related apoptosis-inducing ligand (TRAIL) indicating that it is
not a protein regulated by ActD in TRAIL-resistant synovial ﬁ-
broblasts14. This diversity could be because of the different
time employed in the studies.
Multiple reports have shown that PGE2 plays a crucial
role in the pathogenesis of OA30,31. Increased COX-2 ex-
pression has been reported in cartilage and synovial tissues
from patients with OA or rheumatoid arthritis (RA), and also
in several models of cartilage degradation30e33. Some ﬁnd-
ings suggest that PGE2 mediates the IL-1b effect on carti-
lage degradation34; however, PGE2 may also have
positive effects on cartilage, by increasing the level of glu-
cocorticoid receptors in chondrocyte cells, inﬂuencing carti-
lage differentiation and proliferation, and mediating the
effects of vitamin D on cartilage35. A big controversy exists
about whether or not PGE2 causes cell death
9,24. In our
study, we have found that the levels of PGE2 induced by
IL-1b were much higher than those induced by TNF-a. Inter-
estingly, when ActD was present in the culture medium, the
IL-1b-induced PGE2 levels were signiﬁcantly reduced to
near-basal levels. We then examined, by inhibiting endoge-
nous prostaglandin (PG) synthesis, whether the differences
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Fig. 6. Role of caspases in the differential interaction of IL-1b and
TNF-a with the cell death stimulator, ActD. Flow cytometry analyses
of the DNA content of PI stained in chondrocytes preincubated for
2 h with the indicated caspase inhibitors and then stimulated with
ActD (1 mg/ml) plus IL-1b (5 ng/ml) or TNF-a (10 ng/ml) for 24 h.
Percentage of cells with hypodiploid DNA content induced by IL-
1b/ActD or TNF-a/ActD was taken as 100% for respective compar-
isons vs caspase inhibitors. Values are means S.E.M. of six exper-
iments performed in triplicate (*P< 0.001 and **P< 0.05 vs no
caspase inhibitor, respectively).in PGE2 production between IL-1b- and TNF-a-treated cells
could contribute to the different effects of these cytokines on
cell death. We found that the inhibition of COX with indo-
methacin resulted in an increase in cell death induced by
these cytokines in the presence of ActD. Similar results
were obtained with dexamethasone (DXM) (data not
shown), in agreement with recent ﬁndings published dem-
onstrating that DXM induces apoptosis in proliferative chon-
drocytes through activation of caspases and suppression of
the Akte(PI3K) signaling pathway36.
These results may suggest that the higher levels of PGE2
induced by IL-1b could protect chondrocytes from the cell
death induced by ActD. However, they are contrary to
another report which found that both DNA fragmentation
and reduction in cell viability in response to a NO generator
were inhibited by a COX-2 speciﬁc inhibitor24. In the same
work, the results also demonstrated that exogenous PGE2
may sensitize human OA chondrocytes to cell death in-
duced by NO. On the other hand, the down-regulation of
CD-95-dependent apoptosis by IL-1b was not inﬂuenced
by PGs because the stimulation of chondrocyte cells with
CD-95 and indomethacin or PGE2 did not signiﬁcantly
affect apoptosis induction by CD-959. However, it has
recently been reported that TNF-a-mediated protection of
chondrocytes from NO-induced apoptosis requires COX-2
activity12. Similarly, several studies in the literature indicate
that COX-2 expression plays a role in preventing apoptosis
in a number of cancer cells and macrophages37. It has
also been recently established that SMAC/Diablo is essen-
tial for the apoptosis induced by nonsteroidal anti-inﬂam-
matory drugs (NSAIDs) in colon cancer cells38. One
limitation of our study is that it is not possible to exclude
the implication of other PGs. In this sense, it has been de-
scribed that 15-deoxy-D12,14-prostaglandin J2 (15d-PGJ2)
has an anti-apoptotic effect on chondrocyte cells and
also synovial ﬁbroblasts through the inhibition of ERK1/2
phosphorylation39,40.
NO also plays a crucial role in the pathogenesis of
OA18,19. In this study, we demonstrated that the different
interactions of IL-1b and TNF-a are not inﬂuenced by the
production of endogenous NO because the presence of
both IL-1b and TNF-a in human chondrocytes increases
NO production at the same level and the presence of
ActD in the culture medium signiﬁcantly reduces the NO
induced by IL-1b and TNF-a to basal levels.
TNF-a is known to induce apoptosis in diverse cells
through the recruitment of caspase-8. It has been previ-
ously described that TNF-a/ActD-induced cell death oc-
curred by apoptosis and that it was associated with
caspase activation13. However, little information exists
about the caspase initiator in the IL-1b signal cascade. In
this study, we investigated the relative contribution of cas-
pase-8 vs total caspases in IL-1- and TNF-a-induced cell
death in the presence of ActD. Similar to other work, cell
death was signiﬁcantly inhibited by a caspase-8 inhibitor
and a caspase general inhibitor in TNF-a/ActD-treated
chondrocytes13. However, the cell death induced by IL-1b/
ActD alone was signiﬁcantly prevented by the caspase gen-
eral inhibitor. These results point to possible different re-
quirements for caspases during TNF-a/ActD or IL-1b/ActD
interactions. Finally, several studies show an indirect mech-
anism of TNF-a induced apoptosis by the stimulation of
death receptors (DR) and ligands including TRAIL and
Fas. It is possible that TNF-a synergizes with ActD through
the expression of these DR family members41,42. Different
mechanisms are probably involved in each apoptosis induc-
tion and further investigation is now underway.
668 M. J. Lo´pez-Armada et al.: Differential effect of cytokines on cell deathIn summary, the present set of studies provide evidence,
for the ﬁrst time, that IL-1b and TNF-a cytokines differen-
tially regulate the activation of the apoptotic machinery in
human chondrocytes and that this difference is dependent
on PGE2 levels and caspase-8 activation. These ﬁndings
may be relevant to the understanding of the pathogenesis
of diseases with increased apoptosis of chondrocytes.
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